http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-018848-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5e51ddf1ca3a557cf0c142a4e2fad0e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71f323a409082a2f441a6981290c6720 |
publicationDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EA-018848-B1 |
titleOfInvention | IMMUNOLOGICALLY ACTIVE SUBSTANCE, METHOD FOR ITS OBTAINING, BIOLOGICAL SUBSCRIBERS OF THE MANUALS OF THE ISSU.A. |
abstract | The claimed group of inventions relates to biotechnology, can be used in various branches of medicine to diagnose the state of tissues of an individual’s organs, treat diseases of these tissues, which are characterized by uncontrolled growth of tissue cells and require cessation of growth by local lysis inside the body during mandatory monitoring of treatment and the same substance, which may be the basis for laboratory testing and pharmaceutical compositions. The claimed technical solutions are based on the creation of a new class of substances with immune activity, obtained from tissue of an internal, transient or transplanted organ, neoplasms of an individual organism, which have specific activity against antibodies / autoantibodies and are characterized by the presence of properties that allow the laboratory to detect the state of tissue of internal organs in of an individual by detecting an antigen-antibody, autoantigen-autoantibody reaction occurring between a substance and a biological th liquid withdrawn from an individual having the partial syngeneic organ and species, which can call the response of the individual's immune system when administered parenterally, leading to lysis of the local tissue, organ and species having tropism for injectate. |
priorityDate | 2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 290.